Do analysts rate MOBI or KEQU?

Mobia Medical presently has a consensus price target of $20.75, indicating a potential upside of 95.57%. Given Mobia Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Mobia Medical is more favorable than Kewaunee Scientific. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mobia Medical 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.57 Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to MOBI or KEQU?

In the previous week, Mobia Medical had 11 more articles in the media than Kewaunee Scientific. MarketBeat recorded 12 mentions for Mobia Medical and 1 mentions for Kewaunee Scientific. Mobia Medical's average media sentiment score of 1.66 beat Kewaunee Scientific's score of 1.63 indicating that Mobia Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mobia Medical 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Kewaunee Scientific 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts recommend CARL or KEQU?

Carlsmed currently has a consensus target price of $19.25, indicating a potential upside of 19.94%. Given Carlsmed's stronger consensus rating and higher probable upside, equities research analysts plainly believe Carlsmed is more favorable than Kewaunee Scientific. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Carlsmed 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50 Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor CARL or KEQU?

In the previous week, Carlsmed had 1 more articles in the media than Kewaunee Scientific. MarketBeat recorded 2 mentions for Carlsmed and 1 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.63 beat Carlsmed's score of 0.51 indicating that Kewaunee Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Carlsmed 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Kewaunee Scientific 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts recommend ELMD or KEQU?

Electromed currently has a consensus price target of $37.50, indicating a potential downside of 4.94%. Given Electromed's stronger consensus rating and higher probable upside, research analysts clearly believe Electromed is more favorable than Kewaunee Scientific. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Electromed 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate TLSI or KEQU?

TriSalus Life Sciences currently has a consensus target price of $7.50, suggesting a potential upside of 42.31%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, equities analysts plainly believe TriSalus Life Sciences is more favorable than Kewaunee Scientific. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TriSalus Life Sciences 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor TLSI or KEQU?

In the previous week, TriSalus Life Sciences had 2 more articles in the media than Kewaunee Scientific. MarketBeat recorded 3 mentions for TriSalus Life Sciences and 1 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.63 beat TriSalus Life Sciences' score of 0.62 indicating that Kewaunee Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TriSalus Life Sciences 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Kewaunee Scientific 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Kewaunee Scientific (KEQU) Competitors

$37.07 +0.60 (+1.65%)

As of 08/21/2026 04:00 PM Eastern

Compare

KEQU vs. MOBI, CARL, ELMD, SENS, and TLSI

Should you buy Kewaunee Scientific stock or one of its competitors? Kewaunee Scientific's main competitors and comparable companies include Mobia Medical (MOBI), Carlsmed (CARL), Electromed (ELMD), Senseonics Holdings, Inc. Common Stock (SENS), and TriSalus Life Sciences (TLSI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Kewaunee Scientific compare to Mobia Medical?

Mobia Medical (NASDAQ:MOBI) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

Kewaunee Scientific has a net margin of 3.41% compared to Mobia Medical's net margin of 0.00%. Kewaunee Scientific's return on equity of 14.10% beat Mobia Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mobia Medical	N/A	N/A	N/A
Kewaunee Scientific	3.41%	14.10%	5.55%

Kewaunee Scientific has higher revenue and earnings than Mobia Medical. Mobia Medical is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mobia Medical	$32.04M	11.02	-$46.50M	-$20.18	N/A
Kewaunee Scientific	$282M	0.38	$9.62M	$3.22	11.51

In the previous week, Mobia Medical had 11 more articles in the media than Kewaunee Scientific. MarketBeat recorded 12 mentions for Mobia Medical and 1 mentions for Kewaunee Scientific. Mobia Medical's average media sentiment score of 1.66 beat Kewaunee Scientific's score of 1.63 indicating that Mobia Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mobia Medical	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Kewaunee Scientific	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

32.7% of Kewaunee Scientific shares are held by institutional investors. 14.1% of Kewaunee Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Mobia Medical presently has a consensus price target of $20.75, indicating a potential upside of 95.57%. Given Mobia Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Mobia Medical is more favorable than Kewaunee Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mobia Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Kewaunee Scientific beats Mobia Medical on 9 of the 15 factors compared between the two stocks.

How does Kewaunee Scientific compare to Carlsmed?

Carlsmed (NASDAQ:CARL) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

32.7% of Kewaunee Scientific shares are held by institutional investors. 12.9% of Carlsmed shares are held by insiders. Comparatively, 14.1% of Kewaunee Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Carlsmed had 1 more articles in the media than Kewaunee Scientific. MarketBeat recorded 2 mentions for Carlsmed and 1 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.63 beat Carlsmed's score of 0.51 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Carlsmed	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Kewaunee Scientific	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Carlsmed currently has a consensus target price of $19.25, indicating a potential upside of 19.94%. Given Carlsmed's stronger consensus rating and higher probable upside, equities research analysts plainly believe Carlsmed is more favorable than Kewaunee Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Kewaunee Scientific has higher revenue and earnings than Carlsmed. Carlsmed is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlsmed	$50.51M	8.67	-$29.63M	-$1.43	N/A
Kewaunee Scientific	$282M	0.38	$9.62M	$3.22	11.51

Kewaunee Scientific has a net margin of 3.41% compared to Carlsmed's net margin of -57.42%. Kewaunee Scientific's return on equity of 14.10% beat Carlsmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Carlsmed	-57.42%	-38.06%	-28.96%
Kewaunee Scientific	3.41%	14.10%	5.55%

Summary

Kewaunee Scientific beats Carlsmed on 10 of the 15 factors compared between the two stocks.

How does Kewaunee Scientific compare to Electromed?

Electromed (NYSE:ELMD) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

Kewaunee Scientific has higher revenue and earnings than Electromed. Kewaunee Scientific is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$71.75M	4.55	$5.15M	$1.17	33.72
Kewaunee Scientific	$282M	0.38	$9.62M	$3.22	11.51

Electromed currently has a consensus price target of $37.50, indicating a potential downside of 4.94%. Given Electromed's stronger consensus rating and higher probable upside, research analysts clearly believe Electromed is more favorable than Kewaunee Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Electromed has a net margin of 11.34% compared to Kewaunee Scientific's net margin of 3.41%. Electromed's return on equity of 15.71% beat Kewaunee Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
Kewaunee Scientific	3.41%	14.10%	5.55%

Electromed has a beta of 0.51, suggesting that its stock price is 49% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market.

40.8% of Electromed shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 10.5% of Electromed shares are held by company insiders. Comparatively, 14.1% of Kewaunee Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Kewaunee Scientific had 1 more articles in the media than Electromed. MarketBeat recorded 1 mentions for Kewaunee Scientific and 0 mentions for Electromed. Kewaunee Scientific's average media sentiment score of 1.63 beat Electromed's score of 0.00 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company	Overall Sentiment
Electromed	Neutral
Kewaunee Scientific	Very Positive

Summary

Electromed beats Kewaunee Scientific on 9 of the 16 factors compared between the two stocks.

How does Kewaunee Scientific compare to Senseonics Holdings, Inc. Common Stock?

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

In the previous week, Senseonics Holdings, Inc. Common Stock had 2 more articles in the media than Kewaunee Scientific. MarketBeat recorded 3 mentions for Senseonics Holdings, Inc. Common Stock and 1 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.63 beat Senseonics Holdings, Inc. Common Stock's score of 1.45 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Senseonics Holdings, Inc. Common Stock	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Kewaunee Scientific	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are owned by institutional investors. 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by company insiders. Comparatively, 14.1% of Kewaunee Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Senseonics Holdings, Inc. Common Stock has a beta of 1.01, indicating that its stock price is 1% more volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.72, indicating that its stock price is 28% less volatile than the broader market.

Senseonics Holdings, Inc. Common Stock presently has a consensus price target of $17.20, indicating a potential upside of 77.14%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher probable upside, research analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Kewaunee Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Senseonics Holdings, Inc. Common Stock	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Kewaunee Scientific has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Senseonics Holdings, Inc. Common Stock	$35.26M	11.51	-$69.11M	-$2.23	N/A
Kewaunee Scientific	$282M	0.38	$9.62M	$3.22	11.51

Kewaunee Scientific has a net margin of 3.41% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Kewaunee Scientific's return on equity of 14.10% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Senseonics Holdings, Inc. Common Stock	-225.09%	-165.80%	-80.14%
Kewaunee Scientific	3.41%	14.10%	5.55%

Summary

Kewaunee Scientific beats Senseonics Holdings, Inc. Common Stock on 10 of the 16 factors compared between the two stocks.

How does Kewaunee Scientific compare to TriSalus Life Sciences?

TriSalus Life Sciences (NASDAQ:TLSI) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.

TriSalus Life Sciences currently has a consensus target price of $7.50, suggesting a potential upside of 42.31%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, equities analysts plainly believe TriSalus Life Sciences is more favorable than Kewaunee Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TriSalus Life Sciences	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

TriSalus Life Sciences has a beta of 0.43, suggesting that its share price is 57% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.72, suggesting that its share price is 28% less volatile than the broader market.

Kewaunee Scientific has a net margin of 3.41% compared to TriSalus Life Sciences' net margin of -62.59%. Kewaunee Scientific's return on equity of 14.10% beat TriSalus Life Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TriSalus Life Sciences	-62.59%	N/A	-64.47%
Kewaunee Scientific	3.41%	14.10%	5.55%

In the previous week, TriSalus Life Sciences had 2 more articles in the media than Kewaunee Scientific. MarketBeat recorded 3 mentions for TriSalus Life Sciences and 1 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.63 beat TriSalus Life Sciences' score of 0.62 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TriSalus Life Sciences	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Kewaunee Scientific	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

2.6% of TriSalus Life Sciences shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 16.3% of TriSalus Life Sciences shares are held by insiders. Comparatively, 14.1% of Kewaunee Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Kewaunee Scientific has higher revenue and earnings than TriSalus Life Sciences. TriSalus Life Sciences is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TriSalus Life Sciences	$45.15M	7.19	-$39.23M	-$1.30	N/A
Kewaunee Scientific	$282M	0.38	$9.62M	$3.22	11.51

Summary

Kewaunee Scientific beats TriSalus Life Sciences on 10 of the 16 factors compared between the two stocks.

Get Kewaunee Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KEQU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KEQU vs. The Competition

Export

Metric	Kewaunee Scientific	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$106.34M	$6.02B	$7.37B	$12.85B
Dividend Yield	N/A	1.75%	2.53%	11.08%
P/E Ratio	11.51	26.67	272.60	24.24
Price / Sales	0.38	45.38	618.96	99.78
Price / Cash	6.22	33.24	78.62	53.99
Price / Book	1.38	6.23	13.05	6.20
Net Income	$9.62M	$150.07M	$3.47B	$348.59M
7 Day Performance	1.53%	0.69%	2.09%	0.08%
1 Month Performance	2.01%	8.91%	6.64%	3.88%
1 Year Performance	-35.72%	8.07%	25.02%	16.98%

Kewaunee Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KEQU Kewaunee Scientific	1.3795 of 5 stars	$37.07 +1.6%	N/A	-35.7%	$106.34M	$282M	11.51	1,231	News Coverage Positive News
MOBI Mobia Medical	4.1418 of 5 stars	$11.73 -0.1%	$20.75 +76.9%	N/A	$391.50M	$32.04M	N/A	N/A	Positive News Insider Trade Gap Up High Trading Volume
CARL Carlsmed	1.2851 of 5 stars	$14.88 +8.0%	$19.25 +29.4%	N/A	$376.24M	$63.30M	N/A	100	High Trading Volume
ELMD Electromed	0.6626 of 5 stars	$41.42 +3.0%	$37.50 -9.5%	+94.6%	$333.11M	$71.75M	55.23	160
SENS Senseonics Holdings, Inc. Common Stock	3.4811 of 5 stars	$8.69 +8.2%	$17.20 +97.9%	N/A	$326.48M	$35.26M	N/A	90	News Coverage Positive News Insider Trade Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KEQU) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kewaunee Scientific (KEQU) Competitors

KEQU vs. MOBI, CARL, ELMD, SENS, and TLSI

How does Kewaunee Scientific compare to Mobia Medical?

Summary

How does Kewaunee Scientific compare to Carlsmed?

Summary

How does Kewaunee Scientific compare to Electromed?

Summary

How does Kewaunee Scientific compare to Senseonics Holdings, Inc. Common Stock?

Summary

How does Kewaunee Scientific compare to TriSalus Life Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KEQU vs. The Competition

Kewaunee Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Kewaunee Scientific (KEQU) Competitors

KEQU vs. MOBI, CARL, ELMD, SENS, and TLSI

How does Kewaunee Scientific compare to Mobia Medical?

Is MOBI or KEQU more profitable?

Which has higher valuation and earnings, MOBI or KEQU?

Does the media refer more to MOBI or KEQU?

Do insiders and institutionals have more ownership in MOBI or KEQU?

Do analysts rate MOBI or KEQU?

Summary

How does Kewaunee Scientific compare to Carlsmed?

Do insiders & institutionals have more ownership in CARL or KEQU?

Does the media favor CARL or KEQU?

Do analysts recommend CARL or KEQU?

Which has preferable valuation & earnings, CARL or KEQU?

Is CARL or KEQU more profitable?

Summary

How does Kewaunee Scientific compare to Electromed?

Which has stronger earnings and valuation, ELMD or KEQU?

Do analysts recommend ELMD or KEQU?

Is ELMD or KEQU more profitable?

Which has more volatility and risk, ELMD or KEQU?

Do institutionals and insiders have more ownership in ELMD or KEQU?

Does the media refer more to ELMD or KEQU?

Summary

How does Kewaunee Scientific compare to Senseonics Holdings, Inc. Common Stock?

Does the media prefer SENS or KEQU?

Do insiders & institutionals have more ownership in SENS or KEQU?

Which has more risk and volatility, SENS or KEQU?

Do analysts recommend SENS or KEQU?

Which has stronger valuation & earnings, SENS or KEQU?

Is SENS or KEQU more profitable?

Summary

How does Kewaunee Scientific compare to TriSalus Life Sciences?

Do analysts rate TLSI or KEQU?

Which has more risk and volatility, TLSI or KEQU?

Is TLSI or KEQU more profitable?

Does the media favor TLSI or KEQU?

Do institutionals & insiders believe in TLSI or KEQU?

Which has better earnings and valuation, TLSI or KEQU?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KEQU vs. The Competition

Kewaunee Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools